Saltar al contenido
Merck

μ-δ opioid receptor heteromer-specific signaling in the striatum and hippocampus.

Biochemical and biophysical research communications (2014-07-01)
Noufissa Kabli, Theresa Fan, Brian F O'Dowd, Susan R George
RESUMEN

The μ-δ opioid receptor heteromer activates the pertussis toxin-resistant Gαz GTP-binding protein following stimulation by the δ-agonist deltorphin-II whereas μ- and δ-receptors activate the pertussis toxin-sensitive Gαi3 protein following stimulation by μ- and δ-agonists, respectively. Although the regulation of the μ-δ heteromer is being investigated extensively in vitro, its physiological relevance remains elusive owing to a lack of available molecular tools. We investigated μ-δ heteromer signaling under basal conditions and following prolonged morphine treatment in rodent brain regions highly co-expressing μ- and δ-receptors and Gαz. Deltorphin-II induced Gαz activation in the striatum and hippocampus, demonstrating the presence of μ-δ heteromer signaling in these brain regions. Prolonged morphine treatment, which desensitizes μ- and δ-receptor function, had no effect on μ-δ heteromer signaling in the brain. Our data demonstrate that μ-δ heteromer signaling does not desensitize and is regulated differently from μ- and δ-receptor signaling following prolonged morphine treatment.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Morphine sulfate, European Pharmacopoeia (EP) Reference Standard
Supelco
Morphine for system suitability, European Pharmacopoeia (EP) Reference Standard